Diagnosing PFAS can be challenging, but establishing a thorough symptom history along with specific IgE blood testing can build a fuller picture of patients’ allergic triggers and sensitizations, helping clinicians develop accurate, tailored treatment recommendations and ultimately improve their patients’ quality of life.
Symptoms often get labeled as anxiety, chronic fatigue, early neurodegeneration, IBS, or fibromyalgia. How to prevent the root cause — mold exposure — from going unrecognized.
Incorporating aquatic therapy can enhance patient outcomes and shorten recovery times for health care professionals. In the Chicago suburbs, the demand for such programs is rising.
As healthcare systems actively recalibrate their diagnostic strategies, evolved nasal lavage presents a safer, smarter specimen collection standard that results in more accurate and timely diagnosis plus more effective virus containment.
A delayed diagnosis can cause a progression in severity (from mild to moderate to severe), increased suffering for the entire family, as well as enhance the risk of long-term neurological damage and the time it takes for them to heal.
Public debate is growing, but the real path forward lies in defining autism’s biology — and for the first time, we can.
Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes.
Employee assistance programs have become essential tools for organizations aiming to address mental health challenges, reduce burnout and foster healthier workplaces.
Women most affected by both functional and serious GI conditions, especially in midlife, are often dismissed, misdiagnosed, or forced to endure prolonged waits for specialist care.
Transparent communication, sensitivity to parental concerns, and clear explanations of procedures help boost trust and reduce anxiety for both the patient and the provider.
Alzheimer’s costs American families upwards of $360 billion per year, and with our growing aging population, the disease needs to be more of a public health priority.
As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis.
Choosing the right brain injury rehabilitation program is a critical decision that can shape the future for you or your loved one.
While clinical collaboration platforms have already made a significant impact, there is still much work to be done to ensure that every hospital has the tools and protocols in place to respond to sepsis with the urgency it demands.
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care costs are higher.
RapidAI recently closed a $75 million Series C funding round led by Vista Credit Partners. The company offers an AI platform that helps hospital care teams triage and treat stroke patients more quickly.
Medical robotics startup Noah Medical recently closed a $150 million Series B funding round. The company's robotic platform, called the Galaxy System, was designed to help physicians find, biopsy and diagnose lung cancer lesions with more ease and confidence.
Together, the Tennessee-based health system and health technology company will develop solutions to help clinicians detect diseases faster. The new agreement builds on an existing partnership that focuses on earlier diagnoses for lung cancer.